Home > Resource Center > BioTechnology/Pharmaceutal

• Affitech USA, Inc.
  Affitech USA, Inc. is the US subsidiary of Affitech AS of Oslo, Norway, a human antibody therapeutics company with primary focus in oncology, infectious disease, and inflammation.

• Affymax, Inc.
  Affymax, Inc. is a clinical-stage drug development company that is developing a rich pipeline of synthetic peptide-based drugs against clinically-validated targets for the treatment of kidney diseases and cancer.

• Affymetrix, Inc
  Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets.

• Agilent Technologies Inc.
  As the world’s premier measurement company, Agilent works in close collaboration with engineers, scientists, and researchers around the globe to meet the communications, electronics, life sciences, and chemical analysis challenges of today and tomorrow.

• Align Technology Inc.
  With the introduction of the Invisalign® system in 1999, Align Technology, Inc. pioneered the invisible-orthodontics market. Today, it is the leader in clear-aligner therapy.

• Anesiva, Inc.
  Anesiva (Nasdaq: ANSV) is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel pharmaceutical products for pain management.

• Angioscore
  AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets.

• Aridis Pharmaceuticals
  Aridis Pharmaceuticals, LLC is a private biologics drug development company using formulation and delivery technologies to provide differentiated, high value products.

• ARYx Therapeutics
  ARYx Therapeutics: new drugs with the efficacy of proven therapies and significantly better safety profiles.

• Beckman Coulter
  Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes.

• Benitec Inc.
  Benitec develops RNA interference (RNAi)-based therapeutics to treat serious diseases such as AIDS and hepatitis C.

• Biolog, Inc.
  Biolog, Inc company's product lines have been built upon patented technology that greatly simplifies testing of cells.

• BioTime, Inc.
  BioTime, Inc. is engaged in the research and development of synthetic solutions that can be used for plasma volume expansion, blood replacement during hypothermic (low temperature) surgery, and organ preservation.

• BioVitesse, Inc.
  BioVitesse provides the fast growing industrial microbiological control market with automated in-process monitoring systems to detect and identify bacterial contamination, inside the clean rooms, in less than 4 hours instead of days.

• Bridge Pharmaceuticals, Inc.
  Bridge Pharmaceuticals is a US-based SRI International (formally Stanford Research Institute) spin-off company focused on providing lower cost, FDA compliant drug development services in Asia for US and EU based clients

• BrighTex Bio-Photonics
  BrighTex Bio-Photonics (BTBP), a corporation focused on development of applications for the Imaging, Sensing, and Recognition sector of the bio-photonics industry.

• Cell Genesys, Inc.
  Cell Genesys is focused on the development and commercialization of novel biological therapies for patients with cancer.

• Chiron
  Chiron's PROCLEIX® NAT products are used to test more than 25 million blood donations annually in countries around the world, preventing thousands of HIV-1, hepatitis and West Nile virus transfusion-transmitted infections.

• Connetics (Stiefel)
  Stiefel Laboratories is a specialized pharmaceutical company with a singular, steadfast focus on the advancement of dermatology and skin care around the world.

• CV Therapeutics
  CV Therapeutics, Inc is a biopharmaceutical company focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular and metabolic diseases.

• Cytokinetics, Inc.
  Cytokinetics, Incorporated (Nasdaq: CYTK) is a leading biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton.

• DURECT Corporation
  DURECT Corporation is an emerging specialty pharmaceutical company with multiple proprietary drug delivery platforms, including the SABER™ Delivery System, the ORADUR™ sustained release oral gel-cap technology, and the DURIN™ Biodegradable Implant.

• Entelos, Inc.
  Entelos, Inc. Entelos, Inc. (www.entelos.com) is a biopharmaceutical company focused on discovering and developing new therapies for metabolic and inflammatory disorders.

• EV3
  ev3 is a global leader and best-in-class technology provider for specialists treating a wide range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a comprehensive portfolio of treatment op

• Exelixis
  At Exelixis, our vision is to be a world-class commercial biotechnology company.

• Expression Diagnostics
  Founded in 2000, XDx, Inc. is a molecular diagnostics company based in Brisbane, CA, USA. XDx applies modern genomics technologies to the development of molecular diagnostic assays that translate a patient's immune status into clinically actionable inform

• Fluidigm Corporation
  Fluidigm develops and distributes systems based on integrated fluidic circuits (IFCs). Our systems can play a vital role in the advancement of today’s life science and allied fields, including molecular diagnostics, personalized medicine, and wildlife con

• Genentech
  Genentech, the founder of the biotechnology industry, is a company with a quarter-century track record of delivering on the promise of biotechnology.

• Genomic Health
  Genomic Health, a life science company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical

• Gilead
  Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need.

• Glycometrix
  Glycometrix, Inc., is an emerging life sciences company using complex-sugars from blood serum as biomarkers to detect ovarian cancer.

• Hansen Medical
  Hansen Medical was born from the vision of creating a new generation of advanced medical robotics. A generation that would empower and protect physicians while providing enhanced care for patients. The Sensei™ Robotic Catheter System is the first realizat

• Illumina
  At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, dru

• Institute for OneWorld Health
  The Institute for OneWorld Health develops safe, effective and affordable new medicines for people with infectious diseases in the developing worlds.

• Intarcia
  . Intarcia’s drug development expertise and competitive edge is demonstrated by its ability to stabilize macromolecules and to deliver them in a constant and consistent manner over an extended period of time via the proprietary DUROS® drug delivery platfo

• Intermune
  InterMune, Inc. is a biotechnology company focused on developing and commercializing innovative therapies in pulmonology and hepatology.

• Kosan Biosciences, Inc. - BMC
  Kosan uses molecular biology to develop drugs from polyketide natural products.

• Kyphon
  Kyphon's mission is to be the recognized global leader in restoring spinal function with minimally invasive therapies.

• Linc Pharmaceuticals
  BioPharma Technology Development LLP (BTD) BioPharma Technology Development fosters the commercial development of pharmaceutical and biotechnology products.

• Maxygen
  Maxygen is focused on the development of superior versions of validated major protein pharmaceuticals for the patients who need them. Our lead product candidates address substantial market opportunities in cancer and autoimmune diseases.

• McKesson
  McKesson Corporation has been taking care forward for the health care industry for more than 175 years. As the nation’s oldest and largest health care services company, we combine innovation, technology and process knowledge, strong relationships and a bu

• Monogram Bio
  Monogram is a leader in developing and commercializing innovative products to help guide and improve the treatment of infectious diseases, cancer and other serious diseases.

• Nektar Therapeutics
  Nektar Therapeutics provides industry-leading drug delivery technologies, expertise and manufacturing to enable the development of high-value, differentiated therapeutics.

• Nuvelo
  Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular disease, cancer and other debilitating medical condit

• Onyx Pharmaceuticals
  Onyx Pharmaceuticals is developing innovative small molecule cancer treatments based on a molecular understanding of cancer.

• PDL Biopharma
  PDL BioPharma (PDL) pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases.

• Perlegen Sciences
  Perlegen Sciences, Inc. is working to provide safe and effective medicines to patients worldwide.

• Pharmacyclics, Inc.
  Pharmacyclics is a pharmaceutical company developing and commercializing a patented new class of drugs to treat cancer, atherosclerosis and other diseases.

• Pharmatek Laboratories, Inc.
  Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development organization. Services include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing and stability storage and testing.

• Polygenetics, Inc.
  Polygenetics, Inc. is a biomedical research and development company owning patent rights on porous polymer materials (Cavilink™) that provide near zero-order release of contained drugs.

• Raven Biotechnologies, Inc.
  Raven biotechnologies, inc. develops monoclonal antibody (MAb)-based cancer therapeutics using tissue-specific stem and tumor cells as antigens.

• Rinat Neuroscience (Pfizer)
  Rinat Neuroscience is a privately held biotechnology company dedicated to the discovery and commercialization of novel drugs and drug targets for the major mental and neurodegenerative disorders.

• Sangamo BioSciences
  Sangamo's ZFP technology offers a fundamental new approach to human therapeutics.

• Schering Plough Biopharma
  Schering-Plough Biopharma is a newly formed biologics entity of Schering-Plough Corporation, created in May, 2005, to capitalize on the company’s historic strength in biotechnology.

• SGE, Incorporated
  It is about 35 years since Ernest Dawes established Scientific Glass Engineering in a tiny garage at the backyard of a house in Melbourne, Australia.

• Sirna Theraputics
  Sirna Therapeutics (NASDAQ:RNAI) is a clinical-stage biotechnology company focused on developing therapeutics based on RNA interference (RNAi).

• Symyx
  Through expertise in scientific information management, microscale, parallel experimentation, and contract research, Symyx Technologies enables companies in life sciences, chemicals and energy, and consumer and industrial products to transform scientific

• Target Discovery, Inc.
  Target Discovery’s next generation clinical diagnostics utilize new technologies to uniquely discriminate the specific isoform modifications of protein biomarkers.

• Telik
  Telik, Inc. (Nasdaq: TELK) of Palo Alto, CA is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases

• Theravance
  Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates.

• Thoratec
  For more than 30 years, Thoratec has been committed to developing advanced medical technologies to improve patient survival and quality of life. Thoratec provides the broadest mechanical circulatory support portfolio to treat the full range of clinical ne

• Threshold Pharmaceuticals
  Threshold Pharmaceuticals a biotechnology company focused on the discovery, development and commercialization of drugs based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.

• Trace Genetics, Inc
  Trace Genetics is a rapidly growing Identity Genomics company providing products and services for the Genealogy, Forensics, and Molecular Diagnostics markets.

• Trellis Bioscience, Inc.
  Trellis has developed a breakthrough technology for the characterization of individual cells in unprecedented detail.

• Valentis, Inc.
  Valentis is a biotechnology company engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market.

• Varian
  Varian Medical Systems, Inc., headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachy

• Xenogen Corporation
  Xenogen Corporation combines systems biology and low-light optical imaging to create powerful new biophotonic imaging technology that advances the ability of scientists to explore genes, proteins, pathogens and tumor cells in living animals in real time,

• Xenoport
  XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs

• XOMA (US) LLC
  XOMA is a leader in therapeutic antibodies.

• Zonare Medical Systems
  ZONARE Medical Systems, Inc. is a leading provider of premium compact ultrasound systems. Zone Sonography technology, ZONARE’s unique patented approach to ultrasound imaging, is focused on bringing high performance to all clinical settings, leading to adv